Tag: Amber
iVascular announces Phase II results for Amber liquid embolic
New Phase II data from the OPAL study, evaluating iVascular's novel liquid embolic Amber ahead of its market launch, were presented at the Cardiovascular...
iVascular initiates Opal study with new embolic liquid
iVascular has announced the initiation of Opal, the first-in-human study with the new embolic liquid Amber, based on a radiopaque biocompatible copolymer. Opal is...
